MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-WB-10-0061918
Alventa Pharma Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹142.72 Cr
▲ 82% YoY
Net profit · FY 2025
₹2.04 Cr
Net margin 1.4%
EBITDA · FY 2025
₹5.42 Cr
EBITDA margin 3.8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹35.05 Lakh
Issued & subscribed
Open charges
₹30 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Alventa Pharma Limited
Data last updated:
Alventa Pharma Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24299WB2016PLC225674. Its GSTIN is 03AAECE6019L1ZQ (Punjab). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹35.05 Lakh. It was formerly known as Elder Labs Private Limited. It is led by directors including Rubi Mukhopadhyay and Biswajit Pan.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹142.72 Cr, a growth of 82% compared to the previous year. For the same year it recorded a net profit of ₹2.04 Cr (net margin 1.4%) and EBITDA of ₹5.42 Cr (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 45% over five years.
The company is associated with 1 brand: Alventa Pharma. As per MCA filings, the company has open charges of ₹30 Cr on record. Court records list 20 cases involving the company, including 3 filed by the company and 17 filed against it; 12 cases are pending.
Alventa Pharma Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0061918). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alventapharma.com.
Company details
CIN U24299WB2016PLC225674
Registration Number 225674
Incorporation Date 28 October 2016
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-WB-10-0061918
CIN history
Alventa Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24299WB2016PLC225674, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24299WB2016PLC225674 | Current |
| U24299UP2016PTC087395 | Previous |
| U24299WB2016PTC225674 | Previous |
Key People
Anand Kumar Parmanandka Additional Director Rubi Mukhopadhyay Director Biswajit Pan Director Recognitions & Rankings of Alventa Pharma
Contact details
Alventa Pharma Limited's registered office is in Kolkata, West Bengal. Its website is alventapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressRoom No.79 & 80 3rd Floor, At 55 Biplabi Rash Behari Basu Road (Mehta Building), Kolkata, West Bengal, India – 700001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alventa Pharma Limited, buy the company report.
Comprehensive company report
Alventa Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Alventa Pharma operates one associated brand: Alventa Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures generic drugs, offers CDMO services, and exports pharmaceuticals globally. | alventapharma.com |
Business activity
The main business activity of Alventa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alventa Pharma Limited, buy the company report.
Financials of Alventa Pharma Limited
FY 2025 filings availableAlventa Pharma Limited reported revenue of ₹142.72 Cr (up 82% YoY) for FY 2025.
Revenue · FY 2025
₹142.72 Cr ▲ 82%
Net profit · FY 2025
₹2.04 Cr margin 1.4%
EBITDA · FY 2025
₹5.42 Cr margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 82%
3 years · compounded
▲ 10%
5 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 35%
5 years · compounded
▲ 120%
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 82% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.42 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alventa Pharma Limited, buy the company report.
Board of directors of Alventa Pharma Limited
Alventa Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Kumar Parmanandka Also directs: Aleris Pharmaceuticals Limited, Elder Laboratories Limited, Nicholas Pharma India Limited and 3 more | Additional Director | 29 Apr 2018 | 8 Years 6 Months | Current |
| Rubi Mukhopadhyay Also directs: Smith Stanistreet Pharmaceuticals LLP, Aleris Pharmaceuticals Limited, Elder Laboratories Limited and 2 more | Director | 04 Jun 2018 | 8 Years 4 Months | Current |
| Biswajit Pan Also directs: Aleris Pharmaceuticals Limited, Elder Laboratories Limited, Nicholas Pharma India Limited and 4 more | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Alventa Pharma Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pulse Pharmaceuticals Private Limited | ₹145.08 Cr (FY 2024) | -1.0% | Hyderabad, Telangana, India | |||
| Goodway Chemicals Private Limited | ₹144.1 Cr (FY 2025) | -12.0% | Mumbai, Maharashtra, India | |||
| Immacule Lifesciences Private Limited | ₹143.18 Cr (FY 2025) | 34.0% | Nalagarh, Himachal Pradesh, India | |||
| Alventa Pharma Limitedthis company | ₹142.72 Cr (FY 2025) | ₹2.04 Cr | 1.4% | 82.0% | Kolkata, West Bengal, India | |
| Apotex Pharmachem India Private Limited | ₹142.14 Cr (FY 2024) | -19.0% | Bangalore, Karnataka, India | |||
| Sovereign Pharma Private Limited | ₹142.09 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Svizera Labs Private Limited | ₹142.05 Cr (FY 2022) | 7.0% | Thane, Maharashtra, India | |||
| Ratnatris Pharmaceuticals Private Limited | ₹141.71 Cr (FY 2025) | 35.0% | Ahmedabad, Gujarat, India | |||
| Lyka Labs Limited | ₹140.73 Cr (FY 2025) | 25.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Alventa Pharma Limited, buy the company report.
Auditor
Alventa Pharma Limited is audited by H P JHUNJHUNWALA & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H P JHUNJHUNWALA & COMPANY | FY 2023 | 302139E |
Shareholding
The shareholding of Alventa Pharma Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alventa Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹30 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Nov 2025 | 101189989 | Others | ₹20 Cr | Open | |
| 22 Dec 2023 | 100833805 | Indian Bank | ₹10 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Alventa Pharma Limited has 20 court cases on record: 3 filed by Alventa Pharma, 17 filed against it. 12 cases are pending and 8 are disposed.
Total cases
20
Filed by the company
3
Filed against the company
17
Pending
12
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 7 |
| High courts | 10 | 7 | 5 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Execution petition | Filed against the company by M/S Mahima Life Sciences Private Limited | Pending |
| High Court of Himachal Pradesh | Court case (FAO(OS)) | Filed by the company against Boehringer Ingelheim (India) Pvt. Ltd. and 2 others | Disposed |
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed against the company by an individual | Pending |
| District court, TUMAKURU, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instant of Assistant Drug Controller | Pending |
| District court, Thiruvananthapuram, Kerala | Criminal miscellaneous application | Filed against the company by an individual | Pending |
To see the full case history of Alventa Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alventa Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alventa Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAECE6019L1ZQ | Punjab | Active | 01 Feb 2019 |
| 02AAECE6019L1ZS | Himachal Pradesh | Active | 12 Dec 2019 |
To see the full GST registrations and return filing status of Alventa Pharma Limited, buy the company report.
Recent activity
Alventa Pharma Limited has 9 board changes on record since 2018: 4 appointments and 5 cessations. The latest: Ardhendu Kumar De was appointed as Nominee Director on 03 Aug 2023.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101189989 was registered on 04 Nov 2025.
AGM
Alventa Pharma Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Alventa Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Indian Bank amounted to Rs. 10.00 Cr with Charge ID 100833805 was registered on 22 Dec 2023.
Appointed
Ardhendu Kumar De was appointed as Nominee Director.
Ceased
Natasha Balasaria ceased to be Director.
Appointed
Biswajit Pan was appointed as Director.
Ceased
Jeet Narain Singh ceased to be Director.
Ceased
Phool Chandra Yadav ceased to be Director.
Ceased
Aarti Sharma ceased to be Director.
Appointed
Rubi Mukhopadhyay was appointed as Director.
Ceased
Ramdeo Ram ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Alventa Pharma is an active public limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 2016 (10+ years old) and is registered under CIN U24299WB2016PLC225674.
Alventa Pharma has 3 current directors:
- Anand Kumar Parmanandka - Additional Director
- Rubi Mukhopadhyay - Director
- Biswajit Pan - Director
The latest financial statements of Alventa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Alventa Pharma is 03AAECE6019L1ZQ, registered in Punjab. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAECE6019L1ZS (Himachal Pradesh).
The CIN (Corporate Identification Number) of Alventa Pharma is U24299WB2016PLC225674. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alventa Pharma has 20 court cases on record: 3 filed by the company and 17 filed against it. 12 are pending. Most are in the district courts.
Alventa Pharma was incorporated on 28 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Alventa Pharma by revenue are Pulse Pharmaceuticals Private Limited, Goodway Chemicals Private Limited, Immacule Lifesciences Private Limited, Apotex Pharmachem India Private Limited, Sovereign Pharma Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ardhendu Kumar De was appointed as Nominee Director on 03 Aug 2023. Natasha Balasaria ceased to be Director on 08 Jun 2019. Biswajit Pan was appointed as Director on 07 Jun 2019. Alventa Pharma has 9 board changes on record in total.
Yes, Alventa Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-WB-10-0061918).
Alventa Pharma can be reached through the website alventapharma.com. Its registered office is in Kolkata, West Bengal, India.